Camden National Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.84M Sell
9,919
-910
-8% -$169K 0.27% 68
2025
Q1
$2.27M Buy
10,829
+320
+3% +$67K 0.34% 68
2024
Q4
$1.87M Buy
10,509
+673
+7% +$120K 0.28% 68
2024
Q3
$1.94M Sell
9,836
-150
-2% -$29.6K 0.28% 68
2024
Q2
$1.71M Buy
9,986
+1,985
+25% +$340K 0.26% 70
2024
Q1
$1.46M Sell
8,001
-235
-3% -$42.8K 0.26% 70
2023
Q4
$1.28M Sell
8,236
-619
-7% -$95.9K 0.24% 67
2023
Q3
$1.32M Buy
8,855
+101
+1% +$15.1K 0.27% 65
2023
Q2
$1.18M Sell
8,754
-271
-3% -$36.5K 0.23% 68
2023
Q1
$1.44M Sell
9,025
-1,081
-11% -$172K 0.29% 66
2022
Q4
$1.63M Sell
10,106
-835
-8% -$135K 0.34% 66
2022
Q3
$1.47M Sell
10,941
-155
-1% -$20.8K 0.33% 67
2022
Q2
$1.7M Sell
11,096
-360
-3% -$55.1K 0.35% 67
2022
Q1
$1.86M Sell
11,456
-417
-4% -$67.6K 0.34% 68
2021
Q4
$1.61M Sell
11,873
-68
-0.6% -$9.21K 0.28% 69
2021
Q3
$1.29M Buy
11,941
+270
+2% +$29.1K 0.25% 67
2021
Q2
$1.32M Buy
11,671
+205
+2% +$23.1K 0.25% 69
2021
Q1
$1.24M Buy
11,466
+542
+5% +$58.7K 0.25% 67
2020
Q4
$1.17M Buy
10,924
+245
+2% +$26.3K 0.24% 66
2020
Q3
$935K Buy
10,679
+723
+7% +$63.3K 0.21% 65
2020
Q2
$977K Buy
9,956
+97
+1% +$9.52K 0.24% 62
2020
Q1
$751K Sell
9,859
-219
-2% -$16.7K 0.2% 65
2019
Q4
$893K Sell
10,078
-101
-1% -$8.95K 0.18% 64
2019
Q3
$771K Buy
10,179
+598
+6% +$45.3K 0.17% 65
2019
Q2
$697K Sell
9,581
-254
-3% -$18.5K 0.16% 65
2019
Q1
$792K Sell
9,835
-50
-0.5% -$4.03K 0.19% 57
2018
Q4
$912K Sell
9,885
-565
-5% -$52.1K 0.25% 50
2018
Q3
$988K Sell
10,450
-95
-0.9% -$8.98K 0.24% 52
2018
Q2
$977K Buy
10,545
+20
+0.2% +$1.85K 0.26% 48
2018
Q1
$996K Sell
10,525
-57
-0.5% -$5.39K 0.29% 44
2017
Q4
$1.02M Buy
10,582
+1,093
+12% +$106K 0.3% 43
2017
Q3
$843K Sell
9,489
-220
-2% -$19.5K 0.25% 44
2017
Q2
$704K Sell
9,709
-185
-2% -$13.4K 0.22% 44
2017
Q1
$645K Buy
9,894
+510
+5% +$33.2K 0.2% 47
2016
Q4
$587K Buy
+9,384
New +$587K 0.18% 49